Literature DB >> 11325775

The complexities of predictive genetic testing.

J P Evans1, C Skrzynia, W Burke.   

Abstract

Mesh：

Year:  2001        PMID： 11325775      PMCID： PMC1120190          DOI： 10.1136/bmj.322.7293.1052

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

Review 2.  The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective.

Authors:  S G Post; P J Whitehouse; R H Binstock; T D Bird; S K Eckert; L A Farrer; L M Fleck; A D Gaines; E T Juengst; H Karlinsky; S Miles; T H Murray; K A Quaid; N R Relkin; A D Roses; P H St George-Hyslop; G A Sachs; B Steinbock; E F Truschke; A B Zinn
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

Review 3.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.

Authors:  W Burke; M Daly; J Garber; J Botkin; M J Kahn; P Lynch; A McTiernan; K Offit; J Perlman; G Petersen; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-26       Impact factor: 56.272

4.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

Authors:  J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker
Journal:  N Engl J Med       Date:  1997-05-15       Impact factor: 91.245

5.  Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons.

Authors:  D A Evans; L A Beckett; T S Field; L Feng; M S Albert; D A Bennett; B Tycko; R Mayeux
Journal:  JAMA       Date:  1997-03-12       Impact factor: 56.272

Review 6.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

Review 7.  Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis.

Authors:  D L Witte; W H Crosby; C Q Edwards; V F Fairbanks; F A Mitros
Journal:  Clin Chim Acta       Date:  1996-02-28       Impact factor: 3.786

8.  Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample.

Authors:  G Jarvik; E B Larson; K Goddard; G D Schellenberg; E M Wijsman
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

9.  The genetic attributable risk of breast and ovarian cancer.

Authors:  E B Claus; J M Schildkraut; W D Thompson; N J Risch
Journal:  Cancer       Date:  1996-06-01       Impact factor: 6.860

10.  Challenges in communicating genetics: a public health approach.

Authors:  M J Khoury; J F Thrasher; W Burke; E A Gettig; F Fridinger; R Jackson
Journal:  Genet Med       Date:  2000 May-Jun       Impact factor: 8.822
View more
  49 in total

1.  Predictive genetics and predictive morphology have certain similarities.

Authors:  E Foucar
Journal:  BMJ       Date:  2001-09-01

2.  The genetics of tobacco use: methods, findings and policy implications.

Authors:  W Hall; P Madden; M Lynskey
Journal:  Tob Control       Date:  2002-06       Impact factor: 7.552

3.  Direct-to-consumer sales of genetic services on the Internet.

Authors:  Sarah E Gollust; Benjamin S Wilfond; Sara Chandros Hull
Journal:  Genet Med       Date:  2003 Jul-Aug       Impact factor: 8.822

Review 4.  Criteria influencing the clinical uptake of pharmacogenomic strategies.

Authors:  Jai Shah
Journal:  BMJ       Date:  2004-06-19

Review 5.  Reconsidering the family history in primary care.

Authors:  Eugene C Rich; Wylie Burke; Caryl J Heaton; Susanne Haga; Linda Pinsky; M Priscilla Short; Louise Acheson
Journal:  J Gen Intern Med       Date:  2004-03       Impact factor: 5.128

6.  The prediction of disease risk in genomic medicine.

Authors:  Wayne D Hall; Katherine I Morley; Jayne C Lucke
Journal:  EMBO Rep       Date:  2004-10       Impact factor: 8.807

7.  A research agenda for assessing the potential contribution of genomic medicine to tobacco control.

Authors:  Wayne D Hall
Journal:  Tob Control       Date:  2007-02       Impact factor: 7.552

8.  Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes.

Authors:  Qing Lu; Robert C Elston
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

Review 9.  Molecular signatures of cardiovascular disease risk: potential for test development and clinical application.

Authors:  Heribert Schunkert; Inke R König; Jeanette Erdmann
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 10.  Measuring paternal discrepancy and its public health consequences.

Authors:  Mark A Bellis; Karen Hughes; Sara Hughes; John R Ashton
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.